Perch M, Hayes D Jr., Cherikh WS, Zuckermann A, Harhay MO, Hsich E, Potena L, Sadavarte A, Lindblad K, Singh TP, Stehlik J. The international thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-ninth adult lung transplantation report-2022; focus on lung transplant recipients with Chronic Obstructive Pulmonary Disease. J Heart Lung Transplant. 2022;41:1335–47.
Article PubMed PubMed Central Google Scholar
Ley B, Collard HR, King TE Jr. Clinical course and prediction of survival in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2011;183:431–40.
King TE Jr., Pardo A, Selman M. Idiopathic Pulmonary Fibrosis. Lancet. 2011;378:1949–61.
Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, Kreuter M, Lynch DA, Maher TM, Martinez FJ, et al. Idiopathic Pulmonary Fibrosis (an update) and Progressive pulmonary fibrosis in adults: an Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2022;205:e18–e47.
Article PubMed PubMed Central Google Scholar
Chambers DC, Perch M, Zuckermann A, Cherikh WS, Harhay MO, Hayes D Jr., Hsich E, Khush KK, Potena L, Sadavarte A, et al. The international thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-eighth adult lung transplantation report – 2021; focus on recipient characteristics. J Heart Lung Transplant. 2021;40:1060–72.
Article PubMed PubMed Central Google Scholar
Kolaitis NA, Singer JP. Defining success in lung transplantation: from survival to quality of life. Semin Respir Crit Care Med. 2018;39:255–68.
Collard HR, Ryerson CJ, Corte TJ, Jenkins G, Kondoh Y, Lederer DJ, Lee JS, Maher TM, Wells AU, Antoniou KM, et al. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report. Am J Respir Crit Care Med. 2016;194:265–75.
Article CAS PubMed Google Scholar
Song JW, Hong SB, Lim CM, Koh Y, Kim DS. Acute exacerbation of Idiopathic Pulmonary Fibrosis: incidence, risk factors and outcome. Eur Respir J. 2011;37:356–63.
Article CAS PubMed Google Scholar
Kolb M, Bondue B, Pesci A, Miyazaki Y, Song JW, Bhatt NY, Huggins JT, Oldham JM, Padilla ML, Roman J, Shapera S. Acute exacerbations of progressive-fibrosing interstitial lung Diseases. Eur Respir Rev 2018, 27.
Leuschner G, Behr J. Acute Exacerbation in interstitial lung Disease. Front Med (Lausanne). 2017;4:176.
Chizinga M, Machuca TN, Shahmohammadi A, Patel DC, Innabi A, Alzghoul B, Scheuble V, Pipkin M, Mehrad B, Pelaez A, et al. Lung transplantation for acute exacerbation of interstitial lung Disease. Thorax. 2022;77:364–9.
Dotan Y, Vaidy A, Shapiro WB, Zhao H, Dass C, Toyoda Y, Marchetti N, Shenoy K, Cordova FC, Criner GJ, Mamary AJ. Effect of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplantation Outcome. Chest. 2018;154:818–26.
Jo KW, Hong SB, Kim DK, Jung SH, Kim HR, Choi SH, Lee GD, Lee SO, Do KH, Chae EJ, et al. Long-term outcomes of adult lung transplantation recipients: a single-center experience in South Korea. Tuberc Respir Dis (Seoul). 2019;82:348–56.
Ryerson CJ, Vittinghoff E, Ley B, Lee JS, Mooney JJ, Jones KD, Elicker BM, Wolters PJ, Koth LL, King TE Jr., Collard HR. Predicting survival across chronic interstitial lung Disease: the ILD-GAP model. Chest. 2014;145:723–8.
Yeo HJ. Allocation of Donor lungs in Korea. J Chest Surg. 2022;55:274–6.
Article PubMed PubMed Central Google Scholar
Yu WS, Kim SY, Kim YT, Lee HJ, Park S, Choi SM, Kim DH, Cho WH, Yeo HJ, Park S-i, et al. Characteristics of lung allocation and outcomes of lung transplant according to the Korean urgency status. Yonsei Med J. 2019;60:992–7.
Article PubMed PubMed Central Google Scholar
Egan TM. The lung allocation score goes global. Am J Transplant. 2014;14:1234–5.
Article CAS PubMed Google Scholar
Valapour M, Lehr CJ, Schladt DP, Smith JM, Goff R, Mupfudze TG, Swanner K, Gauntt K. Snyder JJ: OPTN/SRTR 2021 Annual Data Report: lung. Am J Transplant. 2023;23:379–s442.
Wootton SC, Kim DS, Kondoh Y, Chen E, Lee JS, Song JW, Huh JW, Taniguchi H, Chiu C, Boushey H, et al. Viral Infection in acute exacerbation of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2011;183:1698–702.
Article PubMed PubMed Central Google Scholar
Johannson KA, Vittinghoff E, Lee K, Balmes JR, Ji W, Kaplan GG, Kim DS, Collard HR. Acute exacerbation of Idiopathic Pulmonary Fibrosis associated with air pollution exposure. Eur Respir J. 2014;43:1124–31.
Atkins CP, Loke YK, Wilson AM. Outcomes in Idiopathic Pulmonary Fibrosis: a meta-analysis from placebo controlled trials. Respir Med. 2014;108:376–87.
Article CAS PubMed Google Scholar
Collard HR, Yow E, Richeldi L, Anstrom KJ, Glazer C. Suspected acute exacerbation of Idiopathic Pulmonary Fibrosis as an outcome measure in clinical trials. Respir Res. 2013;14:73.
Article PubMed PubMed Central Google Scholar
Tachikawa R, Tomii K, Ueda H, Nagata K, Nanjo S, Sakurai A, Otsuka K, Kaji R, Hayashi M, Katakami N, Imai Y. Clinical features and outcome of Acute Exacerbation of interstitial Pneumonia: collagen vascular diseases-related versus idiopathic. Respiration. 2011;83:20–7.
Kapnadak SG, Raghu G. Lung transplantation for interstitial lung Disease. Eur Respir Rev 2021, 30.
Thabut G, Mal H. Outcomes after lung transplantation. J Thorac Dis. 2017;9:2684–91.
Article PubMed PubMed Central Google Scholar
Studer SM, Levy RD, McNeil K, Orens JB. Lung transplant outcomes: a review of survival, graft function, physiology, health-related quality of life and cost-effectiveness. Eur Respir J. 2004;24:674–85.
Article CAS PubMed Google Scholar
Park JE, Kim SY, Song JH, Kim YS, Chang J, Lee JG, Paik HC, Park MS. Comparison of short-term outcomes for connective tissue disease-related interstitial lung Disease and Idiopathic Pulmonary Fibrosis after lung transplantation. J Thorac Dis. 2018;10:1538–47.
Article PubMed PubMed Central Google Scholar
Mosher CL, Weber JM, Frankel CW, Neely ML, Palmer SM. Risk factors for mortality in lung transplant recipients aged ≥ 65 years: a retrospective cohort study of 5,815 patients in the scientific registry of transplant recipients. J Heart Lung Transplant. 2021;40:42–55.
Lee SH, Park MS, Song JH, Kim YS, Lee JG, Paik HC, Kim SY. Perioperative factors associated with 1-year mortality after lung transplantation: a single-center experience in Korea. J Thorac Dis. 2017;9:4006–16.
Article PubMed PubMed Central Google Scholar
Shimizu D, Otani S, Sugimoto S, Yamamoto H, Tomioka Y, Shiotani T, Miyoshi K, Okazaki M, Yamane M, Toyooka S. Effect of preoperative long-term use of corticosteroids on the development of post-transplant lymphoproliferative disorders after lung transplantation: a single-center experience in Japan. Surg Today. 2022;52:697–704.
Article CAS PubMed Google Scholar
McAnally KJ, Valentine VG, LaPlace SG, McFadden PM, Seoane L, Taylor DE. Effect of pre-transplantation prednisone on survival after lung transplantation. J Heart Lung Transplant. 2006;25:67–74.
Mason DP, Thuita L, Nowicki ER, Murthy SC, Pettersson GB, Blackstone EH. Should lung transplantation be performed for patients on mechanical respiratory support? The US experience. J Thorac Cardiovasc Surg. 2010;139:765–773e761.
Vermeijden JW, Zijlstra JG, Erasmus ME, van der Bij W, Verschuuren EA. Lung transplantation for ventilator-dependent Respiratory Failure. J Heart Lung Transplant. 2009;28:347–51.
Singer JP, Blanc PD, Hoopes C, Golden JA, Koff JL, Leard LE, Cheng S, Chen H. The impact of pretransplant mechanical ventilation on short- and long-term survival after lung transplantation. Am J Transplant. 2011;11:2197–204.
Article CAS PubMed PubMed Central Google Scholar
Drakopanagiotakis F, Markart P, Steiropoulos P. Acute exacerbations of interstitial Lung Diseases: focus on biomarkers. Int J Mol Sci. 2023;24:10196.
Article CAS PubMed PubMed Central Google Scholar
Schupp JC, Binder H, Jäger B, Cillis G, Zissel G, Müller-Quernheim J, Prasse A. Macrophage activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. PLoS ONE. 2015;10:e0116775.
Article PubMed PubMed Central Google Scholar
Shenderov K, Collins SL, Powell JD, Horton MR. Immune dysregulation as a driver of Idiopathic Pulmonary Fibrosis. J Clin Invest 2021, 131.
Comments (0)